Skip to main content
. 2014 Aug 14;2014:386473. doi: 10.1155/2014/386473

Figure 1.

Figure 1

The commonly used structures (1a, 1b 2-Phenoxy-N-phenylacetamide core nucleus with antimycobacterial activity) (1c phenoxy-N-phenylacetamide compounds with potent P-gp inhibitor activities).